| Due Diligence for Asset Managers |
|---|
|
Analyze the public filings of asset managers Dive into the EDGAR, IAPD, CAFR source data |
|
⚲
|
| Keyboard |
| Medicinova Inc | |
|---|---|
| Ticker | MNOV |
| CIK # | 0001226616 |
| CUSIP | 58468P206 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 4350 La Jolla Village Drive Suite 950, San Diego, CA 92122 |
| Source | [EDGAR] |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001226616] | 10-K | |
| [0001226616] | 10-Q | |
| [0001226616] | 3 | |
| [0001226616] | 4 | |
| [0001226616] | 8-K | |
| [0001226616] | SC 13D | |
| [0001226616] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| 3D Investment Partners PTE Ltd | Medicinova Inc | [2021-01-21] | 11.3 |
| BlackRock Inc | Medicinova Inc | [2019-02-08] | 7.0 |
| BlackRock Inc | Medicinova Inc | [2017-01-30] | 5.7 |
| FMR LLC | Medicinova Inc | [2015-09-10] | 0.0 |
| [2013-05-20] | None | ||
| Pyxis Capital LP | Medicinova Inc | [2012-02-09] | 5.2 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Iwaki Yuichi
Employee Stock Option (Right to Buy) · derivative
|
2026-01-16 | Grant | 450,000 | $0.00 | |
|
Matsuda Kazuko
Employee Stock Option (Right to Buy) · derivative
|
2026-01-16 | Grant | 350,000 | $0.00 | |
|
Nagao Hideki
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 20,000 | $0.00 | |
|
Lemerond Nicole
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 20,000 | $0.00 | |
|
Beaver Carolyn
Stock Option (Right to Buy) · derivative
|
2025-06-17 | Grant | 20,000 | $0.00 | |
|
Nagao Hideki
Stock Option (Right to Buy) · derivative
|
2025-02-12 | Grant | 24,500 | $0.00 | |
|
Matsuda Kazuko
Employee Stock Option (Right to Buy) · derivative
|
2025-02-12 | Grant | 100,000 | $0.00 | |
|
Lemerond Nicole
Stock Option (Right to Buy) · derivative
|
2025-02-12 | Grant | 24,500 | $0.00 | |
|
Iwaki Yuichi
Employee Stock Option (Right to Buy) · derivative
|
2025-02-12 | Grant | 100,000 | $0.00 | |
|
Beaver Carolyn
Stock Option (Right to Buy) · derivative
|
2025-02-12 | Grant | 24,500 | $0.00 | |
|
Iwaki Yuichi
Employee Stock Option (Right to Buy) · derivative
|
2025-01-07 | Grant | 400,000 | $0.00 | |
|
Matsuda Kazuko
Employee Stock Option (Right to Buy) · derivative
|
2025-01-07 | Grant | 300,000 | $0.00 | |
|
Lemerond Nicole
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 20,000 | $0.00 | |
|
Nagao Hideki
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 20,000 | $0.00 | |
|
Beaver Carolyn
Stock Option (Right to Buy) · derivative
|
2024-06-11 | Grant | 20,000 | $0.00 | |
|
OBrien Geoffrey
Employee Stock Option (Right to Buy) · derivative
|
2024-01-09 | Grant | 84,000 | $0.00 | |
|
Matsuda Kazuko
Employee Stock Option (Right to Buy) · derivative
|
2024-01-09 | Grant | 157,500 | $0.00 | |
|
Iwaki Yuichi
Employee Stock Option (Right to Buy) · derivative
|
2024-01-09 | Grant | 210,000 | $0.00 | |
|
Lemerond Nicole
Stock Option (Right to Buy) · derivative
|
2023-08-04 | Grant | 18,333 | $0.00 | |
|
Nagao Hideki
Stock Option (Right to Buy) · derivative
|
2023-06-13 | Grant | 20,000 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 30 | 5,400,112 |
| 2025-12-31 | 33 | 5,252,638 |
| 2025-09-30 | 26 | 5,128,148 |
| 2025-06-30 | 24 | 5,166,527 |
| 2025-03-31 | 30 | 5,226,617 |
| 2024-12-31 | 31 | 5,227,084 |
| 2024-09-30 | 31 | 4,951,923 |
| 2024-06-30 | 34 | 4,803,642 |
| 2024-03-31 | 36 | 4,722,112 |
| 2023-12-31 | 35 | 4,968,273 |
| 2023-09-30 | 32 | 4,909,106 |
| 2023-06-30 | 37 | 5,274,705 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |